cbdMD, Inc. (YCBD)Healthcare | Drug Manufacturers - Specialty & Generic | Charlotte, United States | NYSE American
0.50 USD
+0.00
(0.583%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 0.50 |
Hot Take ↕ | Aug. 22, 2026, 2:14 a.m. EDT
The investment case here is structurally broken. The business has endured a catastrophic seven-year decline, losing nearly 99.9% of its value, with six consecutive years of negative annual returns. This is not a temporary downturn; it is a fundamental implosion where the market has repeatedly rejected the company's ability to generate value. While recent price action shows a slight bounce near support, the underlying reality is dire: the company is burning through cash with negative operating and free cash flows, posting massive losses, and facing existential threats like potential product removals. The balance sheet is fragile, with debt exceeding cash reserves, and the forward earnings estimate is deeply negative, signaling continued operational distress. There is no dividend to provide income, and the valuation metrics, while mathematically cheap, reflect a 'value trap' where the price is already priced in a permanent impairment of the business. The statistical forecast offers no guidance, correctly identifying the noise in such a distressed asset. Avoid this security entirely. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.081435 |
| AutoARIMA | 0.167999 |
| AutoETS | 0.168000 |
| MSTL | 0.173059 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 0.32 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.805 |
| Excess Kurtosis | 0.35 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 26.939 |
| Revenue per Share | 2.146 |
| Market Cap | 5,602,522 |
| Trailing P/E | 2.17 |
| Forward P/E | -0.56 |
| Beta | 2.17 |
| Profit Margins | -13.80% |
| Website | https://www.cbdmd.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.3191781 |
| Address1 | 2,101 Westinghouse Blvd |
| Address2 | Suite A |
| All Time High | 3,052.8 |
| All Time Low | 0.465 |
| Ask | 0.5399 |
| Ask Size | 200 |
| Average Analyst Rating | 3.0 - Hold |
| Average Daily Volume10 Day | 126,200 |
| Average Daily Volume3 Month | 186,953 |
| Average Volume | 186,953 |
| Average Volume10Days | 126,200 |
| Beta | 2.174 |
| Bid | 0.47 |
| Bid Size | 3,000 |
| Book Value | 0.773 |
| City | Charlotte |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.5 |
| Current Ratio | 2.499 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 0.5139 |
| Day Low | 0.48 |
| Debt To Equity | 26.939 |
| Display Name | cbdMD |
| Earnings Call Timestamp End | 1,747,340,400 |
| Earnings Call Timestamp Start | 1,747,340,400 |
| Earnings Timestamp End | 1,755,518,400 |
| Earnings Timestamp Start | 1,754,996,340 |
| Ebitda | -1,885,343 |
| Ebitda Margins | -0.09007 |
| Enterprise To Ebitda | -3.005 |
| Enterprise To Revenue | 0.271 |
| Enterprise Value | 5,665,544 |
| Eps Forward | -0.89 |
| Eps Trailing Twelve Months | 0.23 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.5995 |
| Fifty Day Average Change | -0.0995 |
| Fifty Day Average Change Percent | -0.16597164 |
| Fifty Two Week Change Percent | -31.91781 |
| Fifty Two Week High | 2.56 |
| Fifty Two Week High Change | -2.06 |
| Fifty Two Week High Change Percent | -0.8046875 |
| Fifty Two Week Low | 0.465 |
| Fifty Two Week Low Change | 0.034999996 |
| Fifty Two Week Low Change Percent | 0.07526881 |
| Fifty Two Week Range | 0.465 - 2.56 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,510,929,000,000 |
| Float Shares | 10,906,991 |
| Forward Eps | -0.89 |
| Forward P E | -0.56179774 |
| Free Cashflow | -1,052,660 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 42 |
| Fullday Change | 0.0029 |
| Fullday Change Percent | 0.583385 |
| Fullday Price | 0.5 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.57678 |
| Gross Profits | 12,072,941 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.100030005 |
| Held Percent Institutions | 0.08189999 |
| Implied Shares Outstanding | 11,205,045 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,759,190,400 |
| Last Split Date | 1,746,576,000 |
| Last Split Factor | 1:8 |
| Long Business Summary | cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is based in Charlotte, North Carolina. |
| Long Name | cbdMD, Inc. |
| Market | us_market |
| Market Cap | 5,602,522 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_593762098 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -3,079,590 |
| Next Fiscal Year End | 1,790,726,400 |
| Non Diluted Market Cap | 5,570,027 |
| Open | 0.5139 |
| Operating Cashflow | -2,217,871 |
| Operating Margins | -0.20355 |
| Payout Ratio | 0.0 |
| Phone | 704 445 3060 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 0.5 |
| Post Market Time | 1,787,961,010 |
| Previous Close | 0.4971 |
| Price Hint | 4 |
| Price To Book | 0.6468305 |
| Price To Sales Trailing12 Months | 0.2676602 |
| Profit Margins | -0.13799 |
| Quick Ratio | 1.257 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 3.0 |
| Region | US |
| Regular Market Change | 0.0029 |
| Regular Market Change Percent | 0.583385 |
| Regular Market Day High | 0.5139 |
| Regular Market Day Low | 0.48 |
| Regular Market Day Range | 0.48 - 0.5139 |
| Regular Market Open | 0.5139 |
| Regular Market Previous Close | 0.4971 |
| Regular Market Price | 0.5 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 153,727 |
| Return On Assets | -0.15751 |
| Return On Equity | -0.40331 |
| Revenue Growth | 0.206 |
| Revenue Per Share | 2.146 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 11,205,045 |
| Shares Percent Shares Out | 0.044 |
| Shares Short | 493,249 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 560,985 |
| Short Name | cbdMD, Inc. |
| Short Percent Of Float | 0.0468 |
| Short Ratio | 2.21 |
| Source Interval | 15 |
| State | NC |
| Symbol | YCBD |
| Total Cash | 2,118,339 |
| Total Cash Per Share | 0.189 |
| Total Debt | 2,212,264 |
| Total Revenue | 20,931,472 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.23 |
| Trailing P E | 2.173913 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.788875 |
| Two Hundred Day Average Change | -0.28887498 |
| Two Hundred Day Average Change Percent | -0.36618602 |
| Type Disp | Equity |
| Volume | 153,727 |
| Website | https://www.cbdmd.com |
| Zip | 28,273 |